Allicin and health: A comprehensive review

dc.contributor.authorSalehi B.
dc.contributor.authorZucca P.
dc.contributor.authorOrhan I.E.
dc.contributor.authorAzzini E.
dc.contributor.authorAdetunji C.O.
dc.contributor.authorMohammed S.A.
dc.contributor.authorMartins N.
dc.date.accessioned2019-08-01T13:38:39Z
dc.date.available2019-08-01T13:38:39Z
dc.date.issued2019
dc.departmentNiğde ÖHÜ
dc.description.abstractBackground: Allicin is an organosulfur and defensive compound found in garlic (Allium sativum L.) and other Allium species. Its unique odor is easily detectable, and its effects on human health have been studied since ancient times. Scope and approach: In this compressive review we report the presence of allicin in different Allium species, their biosynthesis, pharmacokinetics, absorption, and safety profile. Among the main allicin applications highlight its antimicrobial and antiparasitic properties, reviewed in the present work from in vitro evidence and in vivo studies. Finally, special attention was also given to the allicin state of the art in human health, including in vitro and in vivo assays, and clinical trials, on antioxidant, anticancer, antidiabetic and immunomodulatory effects, besides to its contribution as a cardioprotective agent. Key findings and conclusions: The promising capacity of allicin to interact with thiol groups seems to be directly related to its antimicrobial potential, showing both antibacterial and antifungal activities. Allicin also displayed an interesting potential in the prevention and treatment of several diseases including diabetes mellitus, cardiovascular disease, and cancer. Indeed, its antioxidant and immunomodulatory effects are some of the mechanisms that may explain their biological activities. Future applications should be directed to allicin pharmaceutical formulation, its delivery and its compatibility with food matrices and other drugs due to allicin biosynthesis, instability, reactivity, and volatility. © 2019 Elsevier Ltd
dc.description.sponsorshipConsejo Nacional de Innovación, Ciencia y Tecnología Fuel Cell Technologies Program
dc.description.sponsorshipN. Martins would like to thank the Portuguese Foundation for Science and Technology (FCT–Portugal) for the Strategic project ref. UID/BIM/04293/2013 and “ NORTE2020—Programa Operacional Regional do Norte ” ( NORTE-01-0145-FEDER-000012 ). M. Martorell would like to thank the support offered by CONICYT PIA/APOYO CCTE AFB170007 .
dc.identifier.doi10.1016/j.tifs.2019.03.003
dc.identifier.endpage516
dc.identifier.issn0924-2244
dc.identifier.scopus2-s2.0-85062841243
dc.identifier.scopusqualityQ1
dc.identifier.startpage502
dc.identifier.urihttps://dx.doi.org/10.1016/j.tifs.2019.03.003
dc.identifier.urihttps://hdl.handle.net/11480/1497
dc.identifier.volume86
dc.identifier.wosWOS:000465366700043
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthor[0-Belirlenecek]
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofTrends in Food Science and Technology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAllicin
dc.subjectAllium
dc.subjectAntimicrobial
dc.subjectAntiparasitic
dc.subjectCancer
dc.subjectCardiovascular disease
dc.subjectDiabetes
dc.titleAllicin and health: A comprehensive review
dc.typeReview Article

Dosyalar